Biotech & pharma
New insights into enzymes to help reverse cancer, Alzheimer’s, Parkinson's
27 Apr 2016
New knowledge about the mechanism of specific protein complexes in the body could help in the development of better drugs for the treatment of diseases such as cancer, Parkinson's and Alzheimer's
Hydrogen-bonding pairing helps design better drugs to neutralize gut bacterial infections
28 Mar 2016
End-game for dengue as Indian scientists develop herbal remedy
09 Mar 2016
Indian scientists have developed an effective herbal medicine for the treatment of dengue, in what could be a potent remedy to the disease that affects millions of people within the country and across the world
Mutated gene safeguards against heart attacks
09 Mar 2016
Monsanto threatens pull-out over proposed royalty fee cut on GM seeds
05 Mar 2016
While Mahyco Monsanto Biotech (India), argues that the government has no role in determining trade fee, the government panel was clear in its view that the crop cost for cotton farmers has gone up after MMB substantially raised fees for sub-licensing BT seed technology
Study identifies genes linked to stroke risk
01 Mar 2016
Different organs have their own sexuality: study
24 Feb 2016
New nanotechnology detects biomarkers of cancer
19 Feb 2016
Delivering genes across the blood-brain barrier
12 Feb 2016
Latest articles
Featured articles
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.


